Canada markets closed

Seelos Therapeutics, Inc. (SEEL)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.8650-0.0419 (-4.62%)
At close: 04:00PM EDT
0.8600 -0.00 (-0.58%)
After hours: 04:45PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.36M
Enterprise Value 14.98M
Trailing P/E 0.78
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)192.64
Price/Book (mrq)N/A
Enterprise Value/Revenue 220.46
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.90
52-Week Change 3-99.66%
S&P500 52-Week Change 323.76%
52 Week High 3398.4000
52 Week Low 30.8100
50-Day Moving Average 32.1740
200-Day Moving Average 331.3343

Share Statistics

Avg Vol (3 month) 389.22k
Avg Vol (10 day) 3127.59k
Shares Outstanding 52.61M
Implied Shares Outstanding 62.61M
Float 82.14M
% Held by Insiders 11.31%
% Held by Institutions 119.71%
Shares Short (May 15, 2024) 498.22k
Short Ratio (May 15, 2024) 41.52
Short % of Float (May 15, 2024) 44.59%
Short % of Shares Outstanding (May 15, 2024) 44.52%
Shares Short (prior month Apr 15, 2024) 485.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 24, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3May 16, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,045.77%

Management Effectiveness

Return on Assets (ttm)-172.56%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.97M
Revenue Per Share (ttm)2.19
Quarterly Revenue Growth (yoy)-28.30%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-27.11M
Diluted EPS (ttm)-34.8000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)524k
Total Cash Per Share (mrq)0.24
Total Debt (mrq)13.14M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.10
Book Value Per Share (mrq)-17.36

Cash Flow Statement

Operating Cash Flow (ttm)-18.21M
Levered Free Cash Flow (ttm)-17.07M